Anti-Hypertensive Drugs Market - Forecast(2021 - 2026)

Report Code: HCR 0148 Report Format: PDF + Excel (Delivery in 48 Hrs)

Anti-Hypertensive Drugs Market Overview 

Anti-Hypertensive Drugs Market size is valued at $24.2Bn by 2019, and is anticipated to grow at a CAGR of 4.1% during the forecast period 2020-2025. The Anti-Hypertensive Drugs Market growth rate is attributed to increase in the number of patients suffering from hypertension, lifestyle changes such as dietary habits, increased penetration of generic drug versions and increased prevalence of chronic diseases. Reputable physicians are recommending antihypertensive drugs to treat hypertension or elevated blood pressure. One of the leading causes of heart failure, stroke, peripheral vascular disease, chronic kidney disease and others is long-term high blood pressure. There are many classes of antihypertensive drugs, which have the ability to lower blood pressure by different means, and thus, prevent the complications associated with high blood pressure, including stroke and myocardial infarction. Therefore, increase in prevalence of hypertension is anticipated to increase the Anti-Hypertensive Drugs therapeutics market share.
Hypertension is characterized as a long-term medical condition marked by excessive blood pressure in the arteries, which is elevated persistently. Antihypertensive is used to treat people with elevated blood pressure-also known as hypertension. Hypertension is a serious condition with significant complications including heart attack, heart failure and dementia. Hypertension therefore demands early diagnosis and treatment. Some of the medicinal products used to treat hypertension include diuretics, ACE inhibitors, and vasodilators. From unavailability of promising treatment options with fewer side effects and complications associated with uncontrolled high blood pressure are compelling governments and private organizations to increase their R&D investments and motivating pharmaceutical companies to develop novel therapeutics to avoid incidences including kidney diseases, narrowed blood vessels in the eyes, and metabolic syndromes that can demonstrate better safety and efficacy than the available medications is anticipated to propel the Anti-Hypertensive Drugs Market during the forecast period 2020-2025. For instance, The US Food and Drug Administration (FDA) issued guidance on developing fixed-combination drugs to treat hypertension. This primarily focuses on the clinical development of two-drug combinations of previously approved products. US FDA expects to see a reduction in adverse effects for combinations that include doses below each drugs’ maximum dose compared to single drug regimens at their maximum dose. 

Report Coverage

The report: “Anti-Hypertensive Drugs Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Anti-Hypertensive Drugs Market:
By Therapeutics Type: Diuretics, ACE Inhibitors, Angiotensin Receptor Blockers, Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, Vasodilators and others.
By Dosage Forms: Oral and Injectable.
By Distribution Channel: E-Commerce Websites & Online Drug Stores, Retail Pharmacy, Hospital Pharmacy and Others.
By Geography: North America, Europe, Asia-Pacific and RoW.

Key Takeaways

  • North America dominated the Anti-Hypertensive Drugs Market with a share of 34% in the year 2019.        
  • The factors such as increase in healthcare spending worldwide and increase in hypertension prevalence are amongst the major factor projected to impel growth of Anti-Hypertensive Drugs Market.
  • Raising awareness of hypertension-related complications, increase in geriatric population and sedentary lifestyle are the key factors owing to the growth in the segment during forecast period 2020-2025.

By Therapeutics Type - Segment Analysis
On the basis of therapeutics type, diuretics segment held the major share of the market in terms of revenue and is anticipated to grow with a CAGR of 3.8%. The reason is attributed to the fact that in most patients thiazide diuretics are the cornerstone of hypertension treatment. Hydrochlorothiazide is the diuretic with thiazide most commonly used, resulted in the hike in demand for Anti-Hypertensive Drugs’. In addition, the U.S. Joint National Committee on the prevention, detection, evaluation and treatment of high blood pressure recommends thiazide-type diuretics as one of the preferred hypertension drug treatments and these continuous advancements in this field is anticipated to augment the diuretics segment. 
Apart from this, calcium channel blockers are poised to set the fastest growing segment in the forecast period 2020-2025. This is increasing the global demand owing to lesser side effects of these medicinal products compared with other antihypertensive drugs. In addition, the benefits offered such as positive effects on overall health and reductions in the progression of kidney diseases.

By Geography - Segment Analysis

North America dominated the Anti-Hypertensive Drugs Market with a share of 34% in 2019. The application of Anti-Hypertensive Drugs has grown rapidly over the last few years owing to easy use of antihypertensive medicines. In addition, the rise in hypertension incidence and the rise in geriatric population contribute significantly to market growth in this region. As per report published by the AHA (American heart association), 74.9% of hypertension patients are currently undergoing treatment, and only 52.2% of patients have it under control. AHA projection shows that by 2030, about 41.4% of adults in the United States are poised to have hypertension. Furthermore, some of the key market drivers on the North American anti-hypertension market are demanding for prompt and accurate diagnosis and treatment of hypertension, identification of people predisposed to the disease, presence of technically advanced healthcare infrastructure, and management of the disease prognosis. These factors, as well as the growing innovations in various anti-hypertensive drugs techniques, are anticipated to propel the Anti-Hypertensive Drugs Market during the forecast period 2020-2025.
Asia-Pacific, however, is projected to record the highest growth during the forecast period 2020-2025, owing to a surge in awareness of antihypertensive drug use. In addition, the ever-evolving life science industry is driving market growth in developing economies such as India, China and Malaysia.

Drivers – Anti-Hypertensive Drugs Market

  • Rising awareness of the early detection of the disease

With increasing prevalence of the disease, there has been an increase in awareness campaigns by non-profit and governmental organizations that have enabled improved diagnosis of hypertension. For instance, the Pulmonary Hypertension Association (PHA) offers education programs and has a strong support network which offers patients with right treatment information. Furthermore, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products and reducing the side effects of the procedures, providing a lucrative support to the Anti-Hypertensive Drugs market globally.  

Challenges – Anti-Hypertensive Drugs Market

Lack of awareness and low drug adherence 

The major challenge for the market is the low awareness among the population of antihypertensive drugs. First, most people in developing countries are neglecting their health checks and are unaware of the hypertension condition in them until they detect extreme symptoms. Second, people diagnosed with hypertension do not adhere to their medication schedule and stop taking medication after 1-2 weeks until symptoms return, thus posing a huge challenge to the market for anti-hypertensive drugs. For instance, in 2016, BMC Research notes published a research survey (from a developing country) stating that only 17 percent of the total 112 hypertensive stroke subjects adhered to antihypertensive drugs.

Anti-Hypertensive Drugs Industry Outlook

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Anti-Hypertensive Drugs Market. In 2019, Anti-Hypertensive Drugs Market share is fragmented by the top ten players present in the market. Anti-Hypertensive Drugs Market top 10 companies are AstraZeneca PLC, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd, Lupin Limited, Merck & Co. Inc., Novartis AG, Pfizer Inc., Ranbaxy Laboratories Limited, Sanofi SA and others.


Acquisitions/Product Launches

  • In May 2017, Mankind Pharma, a global pharma company that manufactures and markets a broad range of healthcare products launches anti-hypertensive drug, Zolahart (Azilsartan), a new generation anti-hypertensive drug, offers potent and persistent 24 hours’ blood pressure control. It is proven to be safe for hypertensive patients with comorbid conditions like diabetes or chronic kidney disease (CKD).
  • In April 2015, The US arm of the drug maker, Lupin Pharmaceuticals Inc., launched Amlodipine and Valsartan tablets in various strengths in the US market, for the treatment of hypertension and to lower blood pressure after getting final approval from the United States Food and Drug Administration (USFDA);
1. Anti-Hypertensive Drugs Market Overview
    1.1 Definitions and Scope
2. Anti-Hypertensive Drugs Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Therapeutics Type
    2.3 Key trends by Distribution Channel
    2.4 Key trends by Geography
3. Anti-Hypertensive Drugs Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Patent Analysis – Key Companies
    3.4 Pricing Analysis
4. Anti-Hypertensive Drugs Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Anti-Hypertensive Drugs Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Anti-Hypertensive Drugs Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Anti-Hypertensive Drugs Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Anti-Hypertensive Drugs Market – By Therapeutics Types (Market Size –$Million/$Billion)
    8.1 Diuretics
        8.1.1 Thiazide Diuretics
        8.1.2 Potassium-sparing Diuretics
        8.1.3 Loop Diuretic
        8.1.4 Combination Diuretics
    8.2 ACE Inhibitors
    8.3 Angiotensin Receptor Blockers (ARBs)
    8.4 Calcium Channel Blockers
    8.5 Beta-adrenergic Blockers
    8.6 Renin Inhibitors
    8.7 Vasodilators
    8.8 Others
9. Anti-Hypertensive Drugs Market - By Dosage Forms (Market Size –$Million/$Billion)
    9.1 Oral
    9.2 Injectable
        9.2.1 Intramuscular Injection
        9.2.2 Intravenous Injection
10. Anti-Hypertensive Drugs Market - By Distribution Channel (Market Size –$Million/$Billion)
    10.1 E-commerce Websites & Online Drug Stores
    10.2 Retail Pharmacy
    10.3 Hospital Pharmacy
    10.4 Others
11. Anti-Hypertensive Drugs Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Anti-Hypertensive Drugs Market - Entropy
13. Anti-Hypertensive Drugs Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Anti-Hypertensive Drugs Market – Key Company List by Country Premium Premium
15. Anti-Hypertensive Drugs Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Antihypertensive Drugs Market Overview 2021-2026
Table 2: Antihypertensive Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Antihypertensive Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Antihypertensive Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Antihypertensive Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Antihypertensive Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Antihypertensive Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Antihypertensive Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Antihypertensive Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Antihypertensive Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Antihypertensive Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Antihypertensive Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Antihypertensive Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Antihypertensive Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Antihypertensive Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Antihypertensive Drugs Market Pricing Analysis 2021-2026 (US$)
Table 17: Antihypertensive Drugs Market Opportunities Analysis 2021-2026 (US$)
Table 18: Antihypertensive Drugs Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Antihypertensive Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Antihypertensive Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Antihypertensive Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Antihypertensive Drugs Market Size 2018 (US$)
Table 23: Antihypertensive Drugs Market Forecast Analysis 2021-2026 (US$)
Table 24: Antihypertensive Drugs Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 26: Antihypertensive Drugs Market By Type, Revenue & Volume,By Diuretics, 2021-2026 ($)
Table 27: Antihypertensive Drugs Market By Type, Revenue & Volume,By Angiotensin Converting Enzyme (ACE) Inhibitors, 2021-2026 ($)
Table 28: Antihypertensive Drugs Market By Type, Revenue & Volume,By Angiotensin Receptor Blockers (ARBs), 2021-2026 ($)
Table 29: Antihypertensive Drugs Market By Type, Revenue & Volume,By Calcium Channel Blockers, 2021-2026 ($)
Table 30: Antihypertensive Drugs Market By Type, Revenue & Volume,By Beta Blockers, 2021-2026 ($)
Table 31: North America Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 32: South america Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 33: Europe Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 34: APAC Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 35: Middle East & Africa Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 36: Russia Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 37: Israel Antihypertensive Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 38: Top Companies 2018 (US$)Antihypertensive Drugs Market, Revenue & Volume
Table 39: Product Launch 2018-2019Antihypertensive Drugs Market, Revenue & Volume
Table 40: Mergers & Acquistions 2018-2019Antihypertensive Drugs Market, Revenue & Volume


List of Figures

Figure 1: Overview of Antihypertensive Drugs Market 2021-2026
Figure 2: Market Share Analysis for Antihypertensive Drugs Market 2018 (US$)
Figure 3: Product Comparison in Antihypertensive Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Antihypertensive Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antihypertensive Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antihypertensive Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antihypertensive Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Antihypertensive Drugs Market 2018
Figure 9: Average Selling Price in Antihypertensive Drugs Market 2021-2026
Figure 10: Top Opportunites in Antihypertensive Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Antihypertensive Drugs Market
Figure 12: GlobalBy TypeAntihypertensive Drugs Market Revenue, 2021-2026 ($)
Figure 13: Global Antihypertensive Drugs Market - By Geography
Figure 14: Global Antihypertensive Drugs Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 15: Global Antihypertensive Drugs Market CAGR, By Geography, 2021-2026 (%)
Figure 16: North America Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 17: US Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 30: Brazil Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 59: U.K Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 92: China Antihypertensive Drugs Market Value & Volume, 2021-2026
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Antihypertensive Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Antihypertensive Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 121: Russia Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Antihypertensive Drugs Market Value & Volume, 2021-2026 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Antihypertensive Drugs Market
Figure 130: Developments, 2018-2019*Antihypertensive Drugs Market
Figure 131: Company 1 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Antihypertensive Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Antihypertensive Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Antihypertensive Drugs Market Net Sales Share, By Geography, 2018 (%)